<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-30T07:36:32+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>年末复盘：2020年国内基因治疗领域的融资与交易丨医麦新观察</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/2C20FGgJB5MR16eF-iNRaw</id>
    <link href="https://mp.weixin.qq.com/s/2C20FGgJB5MR16eF-iNRaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>告别昂贵的单细胞测序， 挖掘公共数据库的单细胞测序数据， 不需做实验就能发表文章（1.16-17  网络精讲班）</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/8IyuLTN0_5xpUEGxP6ZbjA</id>
    <link href="https://mp.weixin.qq.com/s/8IyuLTN0_5xpUEGxP6ZbjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>异体CD7 CAR-T 7天达到缓解，12岁肿瘤患儿重获新生丨医麦猛爆料</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/t5nLlDClaj5zvZPQ7m9_Xw</id>
    <link href="https://mp.weixin.qq.com/s/t5nLlDClaj5zvZPQ7m9_Xw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资首发丨正序生物获万物、联新、红杉、泰福天使轮投资—开辟具有自主知识产权的碱基编辑疗法新赛道</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/6xByZpWf7HwrHctZ3ulIgg</id>
    <link href="https://mp.weixin.qq.com/s/6xByZpWf7HwrHctZ3ulIgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Claudin 18.2/PD-L1双抗新药临床试验申请获得CDE受理丨医麦猛爆料</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/u8mdnOMPFZlLHeu22A1vwg</id>
    <link href="https://mp.weixin.qq.com/s/u8mdnOMPFZlLHeu22A1vwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30亿美元布局基因治疗，日本制药巨头安斯泰来罕见病管线重见曙光丨医麦新观察</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/nqxODgmgVoM7fhpJnn0FHg</id>
    <link href="https://mp.weixin.qq.com/s/nqxODgmgVoM7fhpJnn0FHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>仁医界专访丨陈波斌教授：中枢神经系统淋巴瘤诊疗属实不易，多学科合力攻坚开辟新天地</title>
    <updated>2020-12-29T23:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/IP9e-jZcJJlDOmvdBC6zaw</id>
    <link href="https://mp.weixin.qq.com/s/IP9e-jZcJJlDOmvdBC6zaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体依然为王，那些热门的赛道现在入场还来得及吗？丨医麦新观察</title>
    <updated>2020-12-29T11:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/bDJxanW6OZS4xk8Hnv9cFw</id>
    <link href="https://mp.weixin.qq.com/s/bDJxanW6OZS4xk8Hnv9cFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>继默沙东后，阿诺医药携手罗氏！合作探索旗下两款在研产品与PD-L1单抗的联合用药</title>
    <updated>2020-12-29T11:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/0e-C8r2HFw7EBG9A04G4uw</id>
    <link href="https://mp.weixin.qq.com/s/0e-C8r2HFw7EBG9A04G4uw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>强生/杨森靶向c-Met/EGFR的双特异性抗体欧洲递交上市申请丨医麦猛爆料</title>
    <updated>2020-12-29T11:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/hUzYQ9KwpPrwJo5pS4CYfw</id>
    <link href="https://mp.weixin.qq.com/s/hUzYQ9KwpPrwJo5pS4CYfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内CAR-T疗法大放异彩，31张临床批件今年占12张，企业相继登陆资本市场丨医麦猛爆料</title>
    <updated>2020-12-29T11:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/3joiKyhk521MhQq-c5iIlQ</id>
    <link href="https://mp.weixin.qq.com/s/3joiKyhk521MhQq-c5iIlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣昌生物HER2 ADC正式纳入突破性治疗丨医麦猛爆料</title>
    <updated>2020-12-29T11:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/x4-FsuR2KctsgFQr9avUdA</id>
    <link href="https://mp.weixin.qq.com/s/x4-FsuR2KctsgFQr9avUdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张江集团与公卫中心携手，共同构建生物医药生态协同联合体</title>
    <updated>2020-12-29T11:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/RnFMW8SyBypVEHU5xQuvJQ</id>
    <link href="https://mp.weixin.qq.com/s/RnFMW8SyBypVEHU5xQuvJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【邀请函】《治疗用生物制品病毒污染风险控制要点》新书发布会，邀您莅临</title>
    <updated>2020-12-28T09:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/ZejHFPMT_xMiQ5eVPGgkYA</id>
    <link href="https://mp.weixin.qq.com/s/ZejHFPMT_xMiQ5eVPGgkYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年度盘点：2020年NK细胞发展动态丨星耀研究院</title>
    <updated>2020-12-28T09:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/zi9tp6-B6ki7qQJO5cxOFg</id>
    <link href="https://mp.weixin.qq.com/s/zi9tp6-B6ki7qQJO5cxOFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>mRNA三大巨头撑起约6000亿市值，国内mRNA公司一览丨医麦新观察</title>
    <updated>2020-12-28T09:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/-hu0X3rNjUF4Yrg-iu6EUA</id>
    <link href="https://mp.weixin.qq.com/s/-hu0X3rNjUF4Yrg-iu6EUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science子刊：干细胞外泌体miRNA下调促炎细胞因子，激发强大的心肌修复功能丨医麦猛爆料</title>
    <updated>2020-12-27T00:32:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/wt0TyKzLVO47qP7u9tzVOg</id>
    <link href="https://mp.weixin.qq.com/s/wt0TyKzLVO47qP7u9tzVOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>暗流涌动的类器官领域，国内多家企业正在积极布局丨医麦新观察</title>
    <updated>2020-12-27T00:32:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/-O3EeT2mL2QvutYpDl-Mlg</id>
    <link href="https://mp.weixin.qq.com/s/-O3EeT2mL2QvutYpDl-Mlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>宋献民教授：Allo-HSCT治疗T淋巴母细胞淋巴瘤，还需解决WHO、WHEN、HOW 三个问题</title>
    <updated>2020-12-27T00:32:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/xuK9TKQ5euw0KxSqIbavQA</id>
    <link href="https://mp.weixin.qq.com/s/xuK9TKQ5euw0KxSqIbavQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再次携手攻克实体瘤！野马生物和希望之城开启IL13Rα2-CAR T细胞临床试验丨医麦猛爆料</title>
    <updated>2020-12-26T11:02:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/ZxTXUSEl13qbVn1yQu10kQ</id>
    <link href="https://mp.weixin.qq.com/s/ZxTXUSEl13qbVn1yQu10kQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>